Point72 Hong Kong’s Zymeworks ZYME Stock Holding History

Point72 Hong Kong’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-466	Closed	-$21K	–	1417
2019 Q4	$21K	Buy	+466	New	+$16.9K	0.01%	876
2019 Q3	–	Sell	-466	Closed	-$10K	–	1391
2019 Q2	$10K	Hold	466	–	–	﹤0.01%	861
2019 Q1	$8K	Hold	466	–	–	﹤0.01%	777
2018 Q4	$7K	Hold	466	–	–	﹤0.01%	598
2018 Q3	$7K	Hold	466	–	–	﹤0.01%	685
2018 Q2	$7K	Buy	+466	New	+$7.22K	﹤0.01%	685

Other funds holding ZYME

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Point72 Hong Kong's ZYME Position: Q1 2020 in Review

Point72 Hong Kong sold out of Zymeworks (ZYME) in Q1 2020, closing a stake of 466 shares — an estimated $21K sold.

Point72 Hong Kong first reported a position in ZYME in Q2 2018 and held it in 6 quarters. The position peaked at $21K in Q4 2019. 116 funds tracked by Wall St. Rank hold ZYME as of Q1 2020.

Point72 Hong Kong reported no remaining Zymeworks position as of Q1 2020 after selling out during the quarter.
Point72 Hong Kong sold 466 Zymeworks shares in Q1 2020, an estimated $21K.
Point72 Hong Kong first reported a position in Zymeworks in Q2 2018 and held it in 6 quarters.
Point72 Hong Kong's Zymeworks position peaked at $21K in Q4 2019.
116 funds tracked by Wall St. Rank held Zymeworks as of Q1 2020.

Based on Point72 Hong Kong's 13F filing for Q1 2020, filed 15 May 2020.